Literature DB >> 29874997

Pathological Roles of Iron in Cardiovascular Disease.

Motoi Kobayashi1, Tomohiro Suhara1,2, Yuichi Baba1,3, Nicholas K Kawasaki1, Jason K Higa1, Takashi Matsui1.   

Abstract

Iron is an essential mineral required for a variety of vital biological functions. Despite being vital for life, iron also has potentially toxic aspects. Iron has been investigated as a risk factor for coronary artery disease (CAD), however, iron's toxicity in CAD patients still remains controversial. One possible mechanism behind the toxicity of iron is "ferroptosis", a newly described form of irondependent cell death. Ferroptosis is an iron-dependent form of regulated cell death that is distinct from apoptosis, necroptosis, and other types of cell death. Ferroptosis has been reported in ischemiareperfusion (I/R) injury and several other diseases. Recently, we reported that ferroptosis is a significant form of cell death in cardiomyocytes. Moreover, myocardial hemorrhage, a major event in the pathogenesis of heart failure, could trigger the release of free iron into cardiac muscle and is an independent predictor of adverse left ventricular remodeling after myocardial infarction. Iron deposition in the heart can now be detected with advanced imaging methods, such as T2 star (T2*) cardiac magnetic resonance imaging, which can non-invasively predict iron levels in the myocardium and detect myocardial hemorrhage, thus existing technology could be used to assess myocardial iron. We will discuss the role of iron in cardiovascular diseases and especially with regard to myocardial I/R injury. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Myocardial infarction; ferroptosis; iron; ischemia-reperfusion injury; reactive oxygen species.

Mesh:

Substances:

Year:  2018        PMID: 29874997      PMCID: PMC6469984          DOI: 10.2174/1389450119666180605112235

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  103 in total

1.  Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance.

Authors:  Ioannis A Paraskevaidis; Efstathios K Iliodromitis; Demetrios Vlahakos; Dimitrios P Tsiapras; Athanassios Nikolaidis; Aikaterini Marathias; Alkiviadis Michalis; Dimitrios Th Kremastinos
Journal:  Eur Heart J       Date:  2004-11-30       Impact factor: 29.983

Review 2.  Iron status and its association with coronary heart disease: systematic review and meta-analysis of prospective studies.

Authors:  Sudeep Das De; Sreedhar Krishna; Ankeet Jethwa
Journal:  Atherosclerosis       Date:  2014-12-20       Impact factor: 5.162

3.  Iron and the sex difference in heart disease risk.

Authors:  J L Sullivan
Journal:  Lancet       Date:  1981-06-13       Impact factor: 79.321

Review 4.  Myocardial ischemia-reperfusion injury: a neglected therapeutic target.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

5.  Polyol pathway mediates iron-induced oxidative injury in ischemic-reperfused rat heart.

Authors:  Wai Ho Tang; Song Wu; Tak Ming Wong; Sookja Kim Chung; Stephen Sum Man Chung
Journal:  Free Radic Biol Med       Date:  2008-05-15       Impact factor: 7.376

6.  Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction.

Authors:  Javier Ganame; Giancarlo Messalli; Steven Dymarkowski; Frank E Rademakers; Walter Desmet; Frans Van de Werf; Jan Bogaert
Journal:  Eur Heart J       Date:  2009-04-03       Impact factor: 29.983

7.  The Protective Role of Mitochondrial Ferritin on Erastin-Induced Ferroptosis.

Authors:  Yue-Qi Wang; Shi-Yang Chang; Qiong Wu; Yu-Jing Gou; Linpei Jia; Yan-Mei Cui; Peng Yu; Zhen-Hua Shi; Wen-Shuang Wu; Guofen Gao; Yan-Zhong Chang
Journal:  Front Aging Neurosci       Date:  2016-12-20       Impact factor: 5.750

Review 8.  A Review on Iron Chelators in Treatment of Iron Overload Syndromes.

Authors:  Naser Mobarra; Mehrnoosh Shanaki; Hassan Ehteram; Hajar Nasiri; Mehdi Sahmani; Mohsen Saeidi; Mehdi Goudarzi; Hoda Pourkarim; Mehdi Azad
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-10-01

9.  Mitochondrial ferritin expression in adult mouse tissues.

Authors:  Paolo Santambrogio; Giorgio Biasiotto; Francesca Sanvito; Stefano Olivieri; Paolo Arosio; Sonia Levi
Journal:  J Histochem Cytochem       Date:  2007-07-11       Impact factor: 2.479

Review 10.  Dual Role of ROS as Signal and Stress Agents: Iron Tips the Balance in favor of Toxic Effects.

Authors:  Elena Gammella; Stefania Recalcati; Gaetano Cairo
Journal:  Oxid Med Cell Longev       Date:  2016-02-24       Impact factor: 6.543

View more
  36 in total

1.  Evaluation of electrocardiography, echocardiography and cardiac T2* for cardiac complications in beta thalassemia major.

Authors:  Fadime Ersoy Dursun; Gönül Açıksarı; Serçin Özkök; Onur İncealtın
Journal:  Int J Cardiovasc Imaging       Date:  2021-10-08       Impact factor: 2.357

Review 2.  Programmed cell death in aortic aneurysm and dissection: A potential therapeutic target.

Authors:  Abhijit Chakraborty; Yang Li; Chen Zhang; Yanming Li; Scott A LeMaire; Ying H Shen
Journal:  J Mol Cell Cardiol       Date:  2021-09-28       Impact factor: 5.000

3.  Effect of dapagliflozin on the initial estimated glomerular filtration rate dip in chronic kidney disease patients without diabetes mellitus.

Authors:  Ryo Shibata; Kensei Taguchi; Yusuke Kaida; Kei Fukami
Journal:  Clin Exp Nephrol       Date:  2022-09-17       Impact factor: 2.617

4.  Current Status and Prospects of Research on Ischemia-Reperfusion Injury and Ferroptosis.

Authors:  Lin Hou; Xiaodong Li; Chang Su; Kailin Chen; Maoxing Qu
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

5.  Construction and validation of molecular subtypes of coronary artery disease based on ferroptosis-related genes.

Authors:  Lina Ding; Fei Long; Dan An; Jing Liu; Guannan Zhang
Journal:  BMC Cardiovasc Disord       Date:  2022-06-22       Impact factor: 2.174

Review 6.  The Role of Ferroptosis in Adverse Left Ventricular Remodeling Following Acute Myocardial Infarction.

Authors:  Kyoko Komai; Nicholas K Kawasaki; Jason K Higa; Takashi Matsui
Journal:  Cells       Date:  2022-04-20       Impact factor: 7.666

Review 7.  Effects of Ferroptosis on Male Reproduction.

Authors:  Yang Liu; Xuanhong Cao; Chen He; Xinrui Guo; Hui Cai; Aili Aierken; Jinlian Hua; Sha Peng
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

Review 8.  Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury.

Authors:  José Lillo-Moya; Catalina Rojas-Solé; Diego Muñoz-Salamanca; Emiliano Panieri; Luciano Saso; Ramón Rodrigo
Journal:  Antioxidants (Basel)       Date:  2021-04-25

9.  Iron metabolism protein transferrin receptor 1 involves in cervical cancer progression by affecting gene expression and alternative splicing in HeLa cells.

Authors:  Nan Huang; Yaxun Wei; Yi Cheng; Xiaolong Wang; Qi Wang; Dong Chen; Wenjing Li
Journal:  Genes Genomics       Date:  2022-01-23       Impact factor: 1.839

Review 10.  New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications.

Authors:  George J Kontoghiorghes; Annita Kolnagou; Theodora Demetriou; Marina Neocleous; Christina N Kontoghiorghe
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.